Avego BioScience Capital Fund II, L.P.
RaisingEmerging manager
Raising: Form D filed Apr 2026 reports an open-ended (indefinite) offering
- Vintage
- 2026
- Fund size
- $60M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
Avego BioScience Capital focuses on mid-to-late stage venture financings for biotech companies, backing innovative healthcare products and services developed with scientific and operating experience.Inferred from the firm's website
02 · Initial check
$600K to $1M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Balaji Venkataraman, Managing Member of the General Partner
- Alyssa Romano, Chief Compliance Officer of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideAvego is a healthcare investment firm that unites industry expertise and capital with entrepreneurs and management teams.
We invest in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum.
https://avego.com/
06 · Sources
Last verified: Oct 28, 2026